Ask AI

From Smolder to Strategy: Optimizing Early Treatment Decisions in High-Risk SMM and NDMM

Enhance your understanding of measures to use to differentiate high-risk smoldering multiple myeloma from symptomatic myeloma, of how to determine when to treat and when to observe, and about evidence-based, guideline-recommended treatment of high-risk smoldering and newly diagnosed multiple myeloma using an individualized approach through an interactive podcast, Interactive Decision Support Tool, text module with accompanying downloadable slides, and an expert-authored commentary.

Share

Program Content

Activities

Risk and Treatment Options in High Risk SMM
To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2026

Expires: January 28, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from Johnson & Johnson and Sanofi Genzyme.

Johnson & Johnson

Sanofi Genzyme